Pilot Randomized Phase II Study of Celecoxib in Oral Premalignant Lesions
- Author
- PAPADIMITRAKOPOULOU, Vassiliki A1 ; WILLIAM, William N1 ; NATHAN, Cherie-Ann7 ; HELMAN, Joseph I8 ; BAOHENG DU2 ; YUEH, Bevan9 ; BOYLE, Jay O10 ; DANNENBERG, Andrew J2 ; LIPPMAN, Scott M1 ; LEE, J. Jack3 ; ONDREY, Frank G4 ; PETERSON, Douglas E5 ; LEI FENG3 ; ATWELL, Anthea1 ; EL-NAGGAR, Adel K6
[1] Departments of Thoracic/Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States
[2] Department of Medicine, Weill Cornell Medical College and New York Presbyterian Hospital, United States
[3] Department of Biostatistics and Applied Mathematics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States
[4] Department of Otolaryngology, University of Minnesota, Minneapolis, Minnesota, United States
[5] School of Dental Medicine and Neag Comprehensive Cancer Center, University of Connecticut Health Center, Farmington, Connecticut, United States
[6] Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States
[7] Department of Otolaryngology-Head and Neck Surgery, Louisiana State University, Shreveport, Louisiana, United States
[8] Department of Maxillofacial Surgery, University of Michigan, Ann Arbor, Michigan, United States
[9] Department of Otolaryngology-Head and Neck Surgery, University of Washington, Seattle, Washington, United States
[10] Head and Neck Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, United States - Source
Clinical cancer research. 2008, Vol 14, Num 7, pp 2095-2101, 7 p ; ref : 45 ref
- ISSN
- 1078-0432
- Scientific domain
- Medical oncology; Pharmacology drugs
- Publisher
- American Association for Cancer Research, Philadelphia, PA
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Célécoxib Essai clinique phase II Homme Lésion précancéreuse de la cavité buccale Randomisation Traitement Enzyme Inhibiteur cyclooxygenase 2 Inhibiteur enzyme Lésion précancéreuse Oxidoreductases Pathologie de la cavité buccale Prostaglandin-endoperoxide synthase Stomatologie
- Keyword (en)
- Celecoxib Phase II trial Human Oral premalignant lesion Randomization Treatment Enzyme Cyclooxygenase 2 inhibitor Enzyme inhibitor Premalignant lesion Oxidoreductases Oral cavity disease Prostaglandin-endoperoxide synthase Stomatology
- Keyword (es)
- Celecoxib Ensayo clínico fase II Hombre Lesión precancerosa de la cavidad bucal Aleatorización Tratamiento Enzima Inhibidor cyclooxygenase 2 Inhibidor enzima Lesión precancerosa Oxidoreductases Cavidad bucal patología Prostaglandin-endoperoxide synthase Estomatología
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B10 Otorhinolaryngology. Stomatology / 002B10B Upper respiratory tract, upper alimentary tract, paranasal sinuses, salivary glands: diseases, semeiology / 002B10B01 Tumors
- Discipline
- Otorhinolaryngology. Stomatology Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 20300235
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1158/1078-0432.CCR-07-4024 
https://dx.doi.org/10.1158/1078-0432.CCR-07-4024
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1158\/1078-0432.CCR-07-4024\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:73:\"Pilot Randomized Phase II Study of Celecoxib in Oral Premalignant Lesions\";s:9:\"\u0000*\u0000jtitle\";s:24:\"Clinical cancer research\";s:9:\"\u0000*\u0000stitle\";s:16:\"Clin. cancer res\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"14\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:4:\"2095\";s:8:\"\u0000*\u0000epage\";s:4:\"2101\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1078-0432\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:19:\"PAPADIMITRAKOPOULOU\";s:10:\"\u0000*\u0000aufirst\";s:11:\"Vassiliki A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:18:\"WILLIAM, William N\";i:1;s:18:\"NATHAN, Cherie-Ann\";i:2;s:16:\"HELMAN, Joseph I\";i:3;s:10:\"BAOHENG DU\";i:4;s:11:\"YUEH, Bevan\";i:5;s:12:\"BOYLE, Jay O\";i:6;s:20:\"DANNENBERG, Andrew J\";i:7;s:16:\"LIPPMAN, Scott M\";i:8;s:12:\"LEE, J. Jack\";i:9;s:15:\"ONDREY, Frank G\";i:10;s:19:\"PETERSON, Douglas E\";i:11;s:8:\"LEI FENG\";i:12;s:14:\"ATWELL, Anthea\";i:13;s:17:\"EL-NAGGAR, Adel K\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:73:\"Pilot Randomized Phase II Study of Celecoxib in Oral Premalignant Lesions\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:40:\"American Association for Cancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1158\/1078-0432.CCR-07-4024\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:73:\"Pilot Randomized Phase II Study of Celecoxib in Oral Premalignant Lesions\";s:9:\"\u0000*\u0000jtitle\";s:24:\"Clinical cancer research\";s:9:\"\u0000*\u0000stitle\";s:16:\"Clin. cancer res\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"14\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:4:\"2095\";s:8:\"\u0000*\u0000epage\";s:4:\"2101\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1078-0432\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:19:\"PAPADIMITRAKOPOULOU\";s:10:\"\u0000*\u0000aufirst\";s:11:\"Vassiliki A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:18:\"WILLIAM, William N\";i:1;s:18:\"NATHAN, Cherie-Ann\";i:2;s:16:\"HELMAN, Joseph I\";i:3;s:10:\"BAOHENG DU\";i:4;s:11:\"YUEH, Bevan\";i:5;s:12:\"BOYLE, Jay O\";i:6;s:20:\"DANNENBERG, Andrew J\";i:7;s:16:\"LIPPMAN, Scott M\";i:8;s:12:\"LEE, J. Jack\";i:9;s:15:\"ONDREY, Frank G\";i:10;s:19:\"PETERSON, Douglas E\";i:11;s:8:\"LEI FENG\";i:12;s:14:\"ATWELL, Anthea\";i:13;s:17:\"EL-NAGGAR, Adel K\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:73:\"Pilot Randomized Phase II Study of Celecoxib in Oral Premalignant Lesions\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:40:\"American Association for Cancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:29:\"10.1158\/1078-0432.CCR-07-4024\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1158\/1078-0432.CCR-07-4024\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:73:\"Pilot Randomized Phase II Study of Celecoxib in Oral Premalignant Lesions\";s:9:\"\u0000*\u0000jtitle\";s:24:\"Clinical cancer research\";s:9:\"\u0000*\u0000stitle\";s:16:\"Clin. cancer res\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"14\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:4:\"2095\";s:8:\"\u0000*\u0000epage\";s:4:\"2101\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1078-0432\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:19:\"PAPADIMITRAKOPOULOU\";s:10:\"\u0000*\u0000aufirst\";s:11:\"Vassiliki A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:18:\"WILLIAM, William N\";i:1;s:18:\"NATHAN, Cherie-Ann\";i:2;s:16:\"HELMAN, Joseph I\";i:3;s:10:\"BAOHENG DU\";i:4;s:11:\"YUEH, Bevan\";i:5;s:12:\"BOYLE, Jay O\";i:6;s:20:\"DANNENBERG, Andrew J\";i:7;s:16:\"LIPPMAN, Scott M\";i:8;s:12:\"LEE, J. Jack\";i:9;s:15:\"ONDREY, Frank G\";i:10;s:19:\"PETERSON, Douglas E\";i:11;s:8:\"LEI FENG\";i:12;s:14:\"ATWELL, Anthea\";i:13;s:17:\"EL-NAGGAR, Adel K\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:73:\"Pilot Randomized Phase II Study of Celecoxib in Oral Premalignant Lesions\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:40:\"American Association for Cancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1158\/1078-0432.CCR-07-4024\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:73:\"Pilot Randomized Phase II Study of Celecoxib in Oral Premalignant Lesions\";s:9:\"\u0000*\u0000jtitle\";s:24:\"Clinical cancer research\";s:9:\"\u0000*\u0000stitle\";s:16:\"Clin. cancer res\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"14\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:4:\"2095\";s:8:\"\u0000*\u0000epage\";s:4:\"2101\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1078-0432\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:19:\"PAPADIMITRAKOPOULOU\";s:10:\"\u0000*\u0000aufirst\";s:11:\"Vassiliki A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:18:\"WILLIAM, William N\";i:1;s:18:\"NATHAN, Cherie-Ann\";i:2;s:16:\"HELMAN, Joseph I\";i:3;s:10:\"BAOHENG DU\";i:4;s:11:\"YUEH, Bevan\";i:5;s:12:\"BOYLE, Jay O\";i:6;s:20:\"DANNENBERG, Andrew J\";i:7;s:16:\"LIPPMAN, Scott M\";i:8;s:12:\"LEE, J. Jack\";i:9;s:15:\"ONDREY, Frank G\";i:10;s:19:\"PETERSON, Douglas E\";i:11;s:8:\"LEI FENG\";i:12;s:14:\"ATWELL, Anthea\";i:13;s:17:\"EL-NAGGAR, Adel K\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:73:\"Pilot Randomized Phase II Study of Celecoxib in Oral Premalignant Lesions\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:40:\"American Association for Cancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1158\/1078-0432.CCR-07-4024\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:73:\"Pilot Randomized Phase II Study of Celecoxib in Oral Premalignant Lesions\";s:9:\"\u0000*\u0000jtitle\";s:24:\"Clinical cancer research\";s:9:\"\u0000*\u0000stitle\";s:16:\"Clin. cancer res\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"14\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:4:\"2095\";s:8:\"\u0000*\u0000epage\";s:4:\"2101\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1078-0432\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:19:\"PAPADIMITRAKOPOULOU\";s:10:\"\u0000*\u0000aufirst\";s:11:\"Vassiliki A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:18:\"WILLIAM, William N\";i:1;s:18:\"NATHAN, Cherie-Ann\";i:2;s:16:\"HELMAN, Joseph I\";i:3;s:10:\"BAOHENG DU\";i:4;s:11:\"YUEH, Bevan\";i:5;s:12:\"BOYLE, Jay O\";i:6;s:20:\"DANNENBERG, Andrew J\";i:7;s:16:\"LIPPMAN, Scott M\";i:8;s:12:\"LEE, J. Jack\";i:9;s:15:\"ONDREY, Frank G\";i:10;s:19:\"PETERSON, Douglas E\";i:11;s:8:\"LEI FENG\";i:12;s:14:\"ATWELL, Anthea\";i:13;s:17:\"EL-NAGGAR, Adel K\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:73:\"Pilot Randomized Phase II Study of Celecoxib in Oral Premalignant Lesions\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:40:\"American Association for Cancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
